Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
15 09 2021
Historique:
received: 09 08 2021
revised: 28 08 2021
accepted: 31 08 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 9 10 2021
Statut: epublish

Résumé

Coronavirus disease 19 (COVID-19) is caused by an enveloped, positive-sense, single-stranded RNA virus, referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the realm

Identifiants

pubmed: 34572076
pii: cells10092427
doi: 10.3390/cells10092427
pmc: PMC8467010
pii:
doi:

Substances chimiques

Lectins, C-Type 0
Neuropilins 0
Receptors, Virus 0
Spike Glycoprotein, Coronavirus 0
Viral Nonstructural Proteins 0
Peptidyl-Dipeptidase A EC 3.4.15.1
Angiotensin-Converting Enzyme 2 EC 3.4.17.23
Serine Endopeptidases EC 3.4.21.-
TMPRSS2 protein, human EC 3.4.21.-
Furin EC 3.4.21.75

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS Biol. 2008 Sep 16;6(9):e226
pubmed: 18798692
Immunity. 2016 Jan 19;44(1):46-58
pubmed: 26789921
EMBO J. 2005 Apr 20;24(8):1634-43
pubmed: 15791205
Adv Virus Res. 2019;105:93-116
pubmed: 31522710
PLoS Pathog. 2021 Jan 4;17(1):e1009153
pubmed: 33395426
J Biomol Struct Dyn. 2020 Nov 2;:1-14
pubmed: 33131430
Nature. 2020 Jun;582(7811):289-293
pubmed: 32272481
Pathogens. 2021 May 22;10(6):
pubmed: 34067281
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
Blood. 2009 May 21;113(21):5176-85
pubmed: 19270265
Mol Cell. 2005 Jan 7;17(1):93-102
pubmed: 15629720
Cell. 2018 Dec 13;175(7):1931-1945.e18
pubmed: 30550790
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Cell. 2021 Apr 1;184(7):1821-1835.e16
pubmed: 33667349
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
J Biol Chem. 2015 Dec 4;290(49):29120-6
pubmed: 26451046
Cells. 2021 Apr 06;10(4):
pubmed: 33917481
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Dev Cell. 2020 Jun 8;53(5):514-529.e3
pubmed: 32425701
J Mol Liq. 2021 Jul 9;:116942
pubmed: 34305216
Nat Commun. 2015 Feb 11;6:6240
pubmed: 25670642
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
Nature. 2020 Aug;584(7821):450-456
pubmed: 32698192
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
Biochem Biophys Res Commun. 2012 Jun 8;422(3):501-7
pubmed: 22588174
Elife. 2019 Jan 11;8:
pubmed: 30632963
Cell Rep. 2020 Sep 22;32(12):108175
pubmed: 32946807
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
Science. 2020 Aug 21;369(6506):1014-1018
pubmed: 32540904
J Med Chem. 2010 Mar 11;53(5):2215-26
pubmed: 20151671
Nature. 2013 Mar 14;495(7440):251-4
pubmed: 23486063
ACS Cent Sci. 2020 Jun 24;6(6):1009
pubmed: 32607448
N Engl J Med. 2020 Apr 30;382(18):1677-1679
pubmed: 32109012
J Mol Struct. 2021 Dec 15;1246:131124
pubmed: 34305175
Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2005-2011
pubmed: 32638221
Cell. 2021 Jan 7;184(1):76-91.e13
pubmed: 33147444
Adv Virus Res. 2016;96:165-192
pubmed: 27712623
Biochem Pharmacol. 2021 Jan;183:114296
pubmed: 33191206
Immunity. 2011 Sep 23;35(3):426-40
pubmed: 21903422
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
Adv Virus Res. 2016;96:59-126
pubmed: 27712628
FEBS J. 2021 Sep;288(17):5010-5020
pubmed: 33264497
Front Pharmacol. 2018 Nov 06;9:1267
pubmed: 30459621
J Biomol Struct Dyn. 2021 Oct;39(17):6617-6632
pubmed: 32715956
Nat Struct Mol Biol. 2020 Oct;27(10):959-966
pubmed: 32908316
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
J Biomol Struct Dyn. 2021 Aug;39(12):4433-4448
pubmed: 32568013
Nature. 2020 Dec;588(7837):327-330
pubmed: 32942285
Nat Rev Microbiol. 2009 Jun;7(6):439-50
pubmed: 19430490
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):779-788
pubmed: 32526627
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
J Biol Chem. 2020 May 15;295(20):6785-6797
pubmed: 32284326
mBio. 2021 Mar 30;12(2):
pubmed: 33785634
Front Chem. 2021 Jan 15;8:628609
pubmed: 33520943

Auteurs

Jitendra Kumar Chaudhary (JK)

Department of Zoology, Shivaji College, University of Delhi, New Delhi 110027, India.

Rohitash Yadav (R)

Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Rishikesh 249201, India.

Pankaj Kumar Chaudhary (PK)

Molecular Biology & Proteomics Laboratory, Department of Biotechnology, Indian Institute of Technology (IIT), Roorkee 247667, India.

Anurag Maurya (A)

Department of Botany, Shivaji College, University of Delhi, New Delhi 110027, India.

Rakesh Roshan (R)

Department of Zoology, Shivaji College, University of Delhi, New Delhi 110027, India.

Faizul Azam (F)

Department of Pharmaceutical Chemistry and Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Unaizah 51911, Saudi Arabia.

Jyoti Mehta (J)

Department of Physiology, Maharishi Markandeshwar Medical College and Hospital, Solan 173229, India.

Shailendra Handu (S)

Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Rishikesh 249201, India.

Ramasare Prasad (R)

Molecular Biology & Proteomics Laboratory, Department of Biotechnology, Indian Institute of Technology (IIT), Roorkee 247667, India.

Neeraj Jain (N)

Department of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow 226031, India.

Avaneesh Kumar Pandey (AK)

Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.

Puneet Dhamija (P)

Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Rishikesh 249201, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH